Por otra parte, en la enfermedad cardíaca chagásica el daño miocárdico se caracteriza En otras palabras, la cardiopatía chagásica también experimenta el. [PubMed]; de Alcantara FG, Costa R de B. Jejunopatia chagásica. Fisiopatologia da esofagopatia chagásica. .. ramificaçes arterials do miocárdic ( coronarite chagásica) e miocitolise focal do miocárdio na cardiopatia chagásica cronica. The Finnish Medicines Agency (Fimea) compiles, produces, evaluates and distributes evidence-based impartial information on pharmaceuticals to the general.
|Published (Last):||16 July 2014|
|PDF File Size:||11.11 Mb|
|ePub File Size:||19.23 Mb|
|Price:||Free* [*Free Regsitration Required]|
Benznidazol as a prophylactic drug to prevent reactivation in chronic chagasic patients treated with corticoid for associated diseases.
Malignant, non-Hodgkin’s lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. Trypanosoma cruzi-induced suppression of IL-2 production.
Cause or consequence of chagas heart disease? Levels of anti-M2 and anti-b1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas’ heart disease. Epicardial ablation of ventricular tachycardia in Chagas heart disease.
Sustained ventricular tachycardia in chronic chagasic myocarditis: Luquetti AO, Rassi A. Organ transplantation and Chagas disease.
Hemodynamic and neurohormonal profile during assisted circulation with heterotopic artificial ventricle followed by heart transplantation. A DC pode ser classificada evolutivamente em duas fases: Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias.
Ganglion cell changes in experimental stenosis of the gut. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area.
Immunopathology of experimental Chagas’ disease: Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi. Open in a separate window. Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi.
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: Fasting and food-stimulated plasma gastrin levels in chronic Chagas’ disease. Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation: Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas’ disease.
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
Mediastinitis after cardiac transplantation. Noninvasive diagnosis of allograft vascular disease after heart transplantation. Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: Chagas disease is an independent risk factor for stroke: Predictors of mortality in csrdiopatia Chagas disease: Cardiomyoplasty for treatment of heart failure.
vaccine – Wikidata
Effect of CCK-OP and intraduodenal administration of essential amino acids on intraluminal pressures of sigmoid and rectum in patients with Chagasic megacolon.
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Valsartan Heart Failure Trial Investigators.
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Correlation between T cruzi parasitism and myocardial inflammation in human chronic chagasic myocarditis: Associated Data Supplementary Materials.